Entity
  • DiaDeep

    Created in 2022
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    1,534 1,534
  • Activities

  • Technologies

  • Entity types

  • Location

    Lyon, France

    Lyon

    France

  • Employees

    Scale: 11-50

    Estimated: 10

  • Engaged corporates

    29
    5 10
  • Added in Motherbase

    1 year, 2 months ago
Description
  • Value proposition

    Every patient matters, every decision counts !

    Are you familiar with that moment of hesitation when facing a critical decision, knowing that much is at stake and time is of the essence?
    This daily challenge is particularly acute for pathologists and oncologists worldwide, especially when making treatment decisions for cancer patients. A minor error in judgment can have far-reaching consequences on numerous lives.
    To support pathologists and oncologists in these critical decisions, we have developed Ai Copilot applications.
    These tools assist in decision-making, biomarker quantification, and prognosis prediction, utilizing AI technology and histology slides across various cancers such as breast cancer, melanoma, and more.
    With our unique holistic approach, we provide real-time insights that empower pathologists and oncologists, facilitating and securing their decision-making processes.

    Biotech, Digital Pathology, and Artificial Intelligence

  • Original language

    Every patient matters, every decision counts !

    Are you familiar with that moment of hesitation when facing a critical decision, knowing that much is at stake and time is of the essence?
    This daily challenge is particularly acute for pathologists and oncologists worldwide, especially when making treatment decisions for cancer patients. A minor error in judgment can have far-reaching consequences on numerous lives.
    To support pathologists and oncologists in these critical decisions, we have developed Ai Copilot applications.
    These tools assist in decision-making, biomarker quantification, and prognosis prediction, utilizing AI technology and histology slides across various cancers such as breast cancer, melanoma, and more.
    With our unique holistic approach, we provide real-time insights that empower pathologists and oncologists, facilitating and securing their decision-making processes.

Corporate interactions BETA
Corporate TypeTweets Articles
PULSALYS
PULSALYS
Research, Research Services
PULSALYS
Research, Research Services
Other

25 Jun 2024


incubateur-accélérateur emlyon business school incubateur-accélérateur emlyon business school
Professional Training & Coaching
Other

25 Jun 2024


HUB612
HUB612
Startup accelerator & VC, Financial Services
HUB612
Startup accelerator & VC, Financial Services
Other

28 Oct 2023


Sifted
Sifted
Newspaper Publishing
Sifted
Newspaper Publishing
Other

21 Dec 2023


Rennes Ville et Métropole
Rennes Ville et Métropole
Government Administration, French metropolis
Rennes Ville et Métropole
Government Administration, French metropolis
Other

24 Sep 2023


Nantes Métropole
Nantes Métropole
Government Administration, French metropolis
Nantes Métropole
Government Administration, French metropolis
Other

24 Sep 2023


Atlanpole Biotherapies
Atlanpole Biotherapies
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Atlanpole Biotherapies
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

24 Sep 2023


Novacité
Novacité
Professional Training and Coaching
Novacité
Professional Training and Coaching
Other

21 Dec 2023


Pouss@LYS
Pouss@LYS
Financial Services
Pouss@LYS
Financial Services
Other

21 Jul 2024


France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

18 Sep 2024


Similar entities
Loading...
Loading...
Social network dynamics